The Fund seeks to track the investment results of the ICE Biotechnology Index, which measures the performance of US-listed securities of companies that are classified within the Biotechnology Sub-Industry Group. The Fund generally invests at least 90% of its assets in securities of the Underlying Index.
Classification |
Inception Date |
Primary Exchange |
Health/Biotech Funds |
02/05/2001 |
Nasdaq |
Investment Information
Market Cap |
9.12B |
Net Assets |
8.75B |
NAV |
136.75 |
Shares Outstanding |
66.50M |
Avg Daily Vol |
1.62M |
Dividend Yield |
0.30% |
Dividend |
0.10 |
Ex Dividend Date |
12/13/22 |
Detailed Information
Mgmt Co |
BlackRock |
Turnover |
46.00% |
Beta |
0.65 |
P/E |
25.80 |
P/B |
9.27 |
Expense Ratio |
0.44% |
To receive a prospectus
BlackRock
4400 Computer Drive
Westborough, MA 01581
800-474-2737